Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INCYTE CORP Director's Dealing 2025

Aug 5, 2025

30371_dirs_2025-08-05_a3f85213-363c-410b-b6a8-bfb717e0e85b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2025-07-21

Reporting Person: Mayes Patrick A (EVP & Chief Scientific Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 67388 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (right to buy) $105.43 2027-11-06 Common Stock (6381) Direct
Employee Stock Option (right to buy) $68.62 2028-07-01 Common Stock (3148) Direct
Employee Stock Option (right to buy) $72.27 2029-01-03 Common Stock (9459) Direct
Employee Stock Option (right to buy) $85.01 2029-07-01 Common Stock (1642) Direct
Employee Stock Option (right to buy) $80.50 2030-01-16 Common Stock (1643) Direct
Employee Stock Option (right to buy) $106.47 2030-07-01 Common Stock (2292) Direct
Employee Stock Option (right to buy) $90.56 2031-01-14 Common Stock (2293) Direct
Employee Stock Option (right to buy) $83.58 2031-07-01 Common Stock (2263) Direct
Employee Stock Option (right to buy) $74.78 2032-01-18 Common Stock (2623) Direct
Employee Stock Option (right to buy) $77.67 2032-07-01 Common Stock (3055) Direct
Employee Stock Option (right to buy) $83.20 2033-01-19 Common Stock (3225) Direct
Employee Stock Option (right to buy) $61.76 2033-07-13 Common Stock (3942) Direct
Employee Stock Option (right to buy) $61.18 2034-01-17 Common Stock (4246) Direct
Employee Stock Option (right to buy) $64.25 2034-07-14 Common Stock (5222) Direct
Employee Stock Option (right to buy) $71.93 2035-01-16 Common Stock (4737) Direct
Employee Stock Option (right to buy) $68.25 2035-07-14 Common Stock (5846) Direct

Footnotes

F1: This includes:
3,533 restricted stock units ("RSUs") granted on October 1, 2021 that will vest fully on October 1, 2025; 1,128 RSUs granted on July 2, 2022 that will fully on July 2, 2026; 3,079 RSUs granted on January 20, 2023 that will vest fully on January 20, 2027; 2,820 RSUs granted on July 14, 2023 that will vest 1,140 on July 14, 2026 and July 14, 2027; 5,253 RSUs granted on July 15, 2024 that will vest 1,751 on July 15, 2026, July 15, 2027 and July 15, 2028; 39,783 RSUs granted on June 6, 2025 that will vest fully on June 6, 2028; and 7,795 RSUs granted on July 15, 2025 that will vest 25% annually over four years.

F2: As of July 21st, 2025, the award is fully vested and exercisable

F3: Options granted on July 2, 2022 and will vest monthly through July 2, 2026

F4: Options granted on January 20, 2023 and will vest monthly through July 2, 2026

F5: Options granted on July 14, 2023 and will vest monthly through July 14, 2027

F6: Options granted on January 18, 2024 and will vest monthly through July 14, 2027

F7: Options granted on July 15, 2024 and will vest monthly through July 15, 2028

F8: Options granted on January 17, 2025 and will vest monthly through July 15, 2028

F9: Options granted on July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.